Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

<strong>Background<br></strong> Dexamethasone was the first intervention proven to reduce mortality in patients with COVID-19 being treated in hospital. We aimed to evaluate the adoption of corticosteroids in the treatment of COVID-19 in the UK after the RECOVERY trial publication...

Full description

Bibliographic Details
Main Authors: Närhi, F, Moonesinghe, SR, Shenkin, SD, Drake, TM, Mulholland, RH, Donegan, C, Dunning, J, Fairfield, CJ, Girvan, M, Hardwick, HE, Ho, A, Leeming, G, Nguyen-Van-Tam, JS, Pius, R, Russell, CD, Shaw, CA, Spencer, RG, Turtle, L, Openshaw, PJM, Baillie, JK, Harrison, EM, Semple, MG, Docherty, AB, Openshaw, PJ, Carson, G, Alex, B, Andrikopoulos, P, Bach, B, Barclay, WS, Bogaert, D, Chand, M, Chechi, K, Cooke, GS, da Silva Filipe, A, de Silva, T, dos Santos Correia, G, Dumas, ME, Fletcher, T, Green, CA, Greenhalf, W, Griffin, J, Gupta, RK, Hiscox, JA, Ho, AY, Horby, PW, Ijaz, S, Khoo, S, Klenerman, P, Law, A, Lewis, M, Mentzer, AJ, Sigfrid, L
Format: Journal article
Language:English
Published: Elsevier 2022

Similar Items